Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.171”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [171]
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Self-citationInfection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Self-citationValidation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Mac Donald, R., Baken, L., Nelson, A., & Nichol, K. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00159-7 · Cited by 410
Self-citationAcute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Vu, T., Farish, S., Jenkins, M., & Kelly, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00041-5 · Cited by 376
Research works printed but not linked: 7
- 2002, MMWR Morb Mortal Wkly Rep, 51, 1
- Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford, England: Blackwell Science, 1998:358-72.
- Becher H, 2000, J Epidemiol Biostat, 5, 277
- 1999, MMWR Morb Mortal Wkly Rep, 48, 374
- 2000, MMWR Morb Mortal Wkly Rep, 49, 375
- 1997, MMWR Morb Mortal Wkly Rep, 46, 1
- Healthy People 2010: conference edition. Vol. 1. Washington, D.C.: Department of Health and Human Services, January 2000.
Cited by
Items 501–600 of 742
Yoo, B. W., Kim, C. O., Izu, A., Arora, A. K., & Heijnen, E. (2018) · Infection and Chemotherapy · doi:10.3947/ic.2018.50.4.301 · Cited by 10
“Influenza is a serious disease, especially in older adults as it can lead to excess morbidity, hospitalization, and mortality in this age group [13] Therefore, vaccination against influenza is recommended for this population as it can reduce mortality, the incidence of hospitalizations, and associated complications su…”
BackgroundVerhees, R. A. F., Thijs, C. T., Ambergen, T., Dinant, G., & Knottnerus, J. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216983 · Cited by 8
Ältere Patienten mit kardiovaskulären Erkrankungen
Müller‐Werdan, U., Meisel, M., Schirdewahn, P., & Werdan, K. (2007) · Der Internist · doi:10.1007/s00108-007-1941-7 · Cited by 8
Deaths following influenza vaccination—background mortality or causal connection?
Kokia, E. S., SILVERMAN, B. G., Green, M. S., Kedem, H., Guindy, M., & Shemer, J. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.021 · Cited by 8
¿Podemos mejorar las tasas de vacunación antigripal en los ancianos con enfermedades crónicas?
Chávarri, H. S., López, J. L. O., Vílchez, A. L., Carbonell, V. P., Orozco‐Beltrán, D., & Gil-Guillén, V. F. (2005) · Atención Primaria · doi:10.1157/13072586 · Cited by 8
Asthma and Influenza Vaccination
Eisner, M. D. (2003) · CHEST Journal · doi:10.1378/chest.124.3.775 · Cited by 8
Ma, Y., Lu, F., Suo, L., Li, W., Qian, J., Wang, T., Lv, M., Wu, J., Yang, W., Guo, M., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00969-y · Cited by 7
Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics
Yedlapati, S. H., Mendu, A., Tummala, V. R., Maganti, S. S., Nasir, K., & Khan, S. U. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac110 · Cited by 7
“55)] 1999–2000 seasons.(46) The United Kingdom General Practice Research Database (2001 and 2007) showed that influenza vaccination was associated with a reduced rate of acute MI [adjusted OR, 0.”
BackgroundRogers, K. C., Wallace, J. P., Foster, S. L., & Finks, S. W. (2012) · Southern Medical Journal · doi:10.1097/smj.0b013e31824e8db6 · Cited by 7
“Stroke and Transient Ischemic Attack Many studies also have produced results linking influenza vaccination to reduced rates of brain infarction.(23,25,29,30) A case-control study evaluated 90 patients older than 60 years presenting with stroke and 180 matched controls.”
BackgroundMethodLai, H. M., Aronow, W. S., & Gutwein, A. H. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181400114 · Cited by 8
“Vaccination against influenza was associated with a 48% significant reduction in the first winter season and with a 50% significant reduction in the second winter season for all-cause mortality.(9) At 1-year follow up of 301 patients with acute coronary syndromes during the winter season, the incidence of cardiovascul…”
BackgroundInfluentialFrancisco, P. M. S. B., Barros, M. B. D. A., Segri, N. J., Alves, M. C. G. P., César, C. L. G., Carandina, L., & Goldbaun, M. (2013) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2013000600012 · Cited by 15
Greist, J. H., & Jefferson, J. W. (2007) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.5.3.foc283 · Cited by 10
Donowitz, G. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00064-3 · Cited by 13
Cho, H. M., Kim, J.-Y., Hwang, S. E., Kim, J. C., Kim, M.-Y., & Lee, S. H. (2015) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2015.36.4.186 · Cited by 7
Song, B. G., Wi, Y. M., Lee, Y., Hong, C. K., Chun, W. J., & Oh, J. H. (2012) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2012.06.015 · Cited by 9
Sribhutorn, A., Phrommintikul, A., Wongcharoen, W., Chaikledkaew, U., Eakanunkul, S., & Sukonthasarn, A. (2016) · Cardiology Research and Practice · doi:10.1155/2016/4097471 · Cited by 7
Burke, M. (2018) · Current Geriatrics Reports · doi:10.1007/s13670-018-0258-9 · Cited by 8
Universal Influenza Vaccination: The Time to Act Is Now
Mair, M., Grow, R. W., Mair, J. S., & Radonovich, L. J. (2006) · Biosecurity and Bioterrorism Biodefense Strategy Practice and Science · doi:10.1089/bsp.2006.4.20 · Cited by 7
Battistoni, A., & Volpe, M. (2022) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-022-00540-7 · Cited by 9
Liang, C., Polkowska, A., Lade, C., Bayer, L. J., Bruyndonckx, R., Huebbe, B., Ewnetu, W. B., Peerawaranun, P., Casas, M., Tran, T. M. P., et al. (2025) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70097 · Cited by 6
“Thus, the potential impact of a vaccine preventing cardiovascular events, as observed for the influenza vaccine [40, 41], might be substantial.”
Lei, J., Zheng, L.-Z., Chen, K., Yang, X., Yue, T., Qiu, Z., & Chen, L. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133246 · Cited by 7
Aghebati, T., Mohammadpour, A. H., Afshar, M., Jaafari, M. R., Abnous, K., Nazemi, S., Issazadeh, S., Hashemzadeh, S., Zare, M., & Badiee, A. (2016) · PubMed Central · doi:10.22038/ijbms.2016.7922 · Cited by 7
La vacunación en la insuficiencia cardiaca: una estrategia que mejora el pronóstico
Kadoglou, N. P. E., Parissis, J., Seferovic, P., & Filippatos, G. S. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.01.030 · Cited by 6
Wytyczne ESC dotyczące postępowania w stabilnej chorobie wieńcowej w 2013 roku
ESC, E. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0280 · Cited by 18
Burns, F. (2006) · Cited by 6
Drug Therapies to Prevent Coronary Plaque Rupture and Erosion: Present and Future
Kovanen, P. T., Mäyränpää, M. I., & Lindstedt, K. A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_28 · Cited by 6
“Therefore, the recommendation of annual influenza vaccination to elderly and other vulnerable patient groups is reasonable (Nichol et al. 2003; Gurfinkel et al. 2004).”
BackgroundInflammation: The classic double-edged sword
Kurlansky, P. A. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.11.070 · Cited by 6
“Inflammation has not only been implicated in the potential pleomorphic benefits of statins but has been offered as an explanation for the association of cardiovascular disease with periodontal disease,(2) as well as for the reduced incidence of cardiac events after the receipt of influenza vaccine.(3) The inflammatory…”
BackgroundKale, S. S., Ahuja, N., & Yende, S. P. (2012) · Springer eBooks · doi:10.1007/978-94-007-5061-6_14 · Cited by 5
Investigating the association between influenza vaccination and reduced stroke risk
Lichy, C., & Grau, A. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.4.535 · Cited by 5
Community-acquired pneumonia in elderly patients
Chang, H. (2010) · The Korean Journal of Internal Medicine · Cited by 5
Matthias, A. T., & Ekanayaka, R. (2013) · Heart Asia · doi:10.1136/heartasia-2013-010250 · Cited by 5
Vaccinations in Older Adults: Focus on Pneumococcal, Influenza and Herpes zoster infections
Kau, L., Sadowski, C. A., & Hughes, C. A. (2011) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.3821/1913-701x-144.3.132 · Cited by 5
“Clinical outcomes were incidences of mortality, hospitalization, cultureconfirmed influenza, diagnosed pneumonia and influenza-like illness, which consists of symptoms related to influenza regardless of culture results.(36-53) In community-dwelling older adults, the influenza vaccine significantly reduced all-cause mo…”
BackgroundMarano, G., Boracchi, P., Luconi, E., Pariani, E., Pellegrinelli, L., Galli, C., Gandolfi, C. E., Magoni, M., Piro, A., Scarcella, C., et al. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1874927 · Cited by 5
“As in other reports [4,16,17], influenza vaccine recipients in our study resulted more likely to be older and to be affected by existing comorbidity at baseline, including hypertension, diabetes, dysplasia, and neoplastic diseases [9], compared to non-recipients.”
MethodResultChen, C., Lin, C.-H., Hao, W., Yeh, J. S., Chiang, K., Fang, Y.-A., Chiu, C.-C., Yang, T. Y., Wu, Y., & Liu, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.731844 · Cited by 6
“Different Risks of VA Occurrence on Gender, Age, Comorbidities, and Influenza/Non-Influenza Seasons Earlier studies have revealed that patients with a mean age of ∼65 years had a low risk of major cardiovascular events upon receiving influenza vaccination (15, 31, 32).”
BackgroundCho, H., Houle, S. K. D., & Alsabbagh, M. W. (2023) · Health Promotion and Chronic Disease Prevention in Canada · doi:10.24095/hpcdp.43.2.04 · Cited by 7
Nicklas, J. M., Bleske, B. E., Harrison, R. V., Hogikyan, R. V., Kwok, Y. S., & Chavey, W. E. (2013) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2012.11.010 · Cited by 6
“In an observational study including more than 140,000 individuals aged 65 years or older, influenza vaccination was associated with 19% and 27% reductions in the risk of hospitalization for HF in consecutive years.(79)”
Thiberville, S.-D., Gaudart, J., Raoult, D., & Charrel, R. N. (2015) · BMC Public Health · doi:10.1186/s12889-015-1887-y · Cited by 5
“Since cardio-vascular diseases are reduced by the influenza vaccination in elderly patients [17], we considered it interesting to analyse the excess cardiovascular mortality attributable to influenza.”
Background[Influenza and pneumococcal immunization in cardiovascular prevention].
Liprandi, M. I. S., Liprandi, Á. S., Fernández, A., Stecher, D., Bonvehí, P., & Verón, M. T. (2014) · PubMed · Cited by 5
Community‐acquired pneumonia: A practical approach to management for the hospitalist
Sharpe, B. A., & Flanders, S. A. (2006) · Journal of Hospital Medicine · doi:10.1002/jhm.95 · Cited by 6
“Vaccination is safe and effective with almost any medical illness, and both vaccines can be given simultaneously at discharge.(69) Both JCAHO and CMS have defined administration of the pneumococcal and influenza vaccines to patients hospitalized with CAP as a quality measure.”
BackgroundEvaluation on the implementation of respiratory protection measures in old age homes
Lee, D., Yu, D. S. F., Ip, M., & Tang, J. Y. ‐. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s142522 · Cited by 6
Vaccination in Heart Failure: An Approach to Improve Outcomes
Kadoglou, N. P. E., Parissis, J., Seferovic, P. M., & Filippatos, G. S. (2018) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2018.02.012 · Cited by 5
A multi-criteria decision making approach to identify a vaccine formulation
Dewé, W., Durand, C., Marion, S., Oostvogels, L., Devaster, J., & Fourneau, M. (2015) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2015.1008517 · Cited by 5
“A new adjuvanted vaccine was thus developed for improved prevention of the disease and its potential complications in this elderly population (Vu et al., 2002; Nichol et al., 2003; Nichol et al., 2007).”
BackgroundCampagna, A. D. S., Duarte, E. C., Daufenbach, L. Z., & Dourado, I. C. (2014) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-49742014000100003 · Cited by 35
Efetividade da vacina antigripal na época 2010-2011 em Portugal: Resultados do projeto EUROEVA
Jorge, I. N. D. S. D. R., Nunes, B., Machado, A., Engenheira Química, I., Pechirra, P., Licenciatura em Biologia, I., Falcão, I., Chefe de Serviço de Medicina Geral e Familiar, D.-G. D. S., Gonçalves, P., Licenciatura em Biologia Aplicada (Biotecnologia), I., et al. (2012) · Revista Portuguesa de Clínica Geral · doi:10.32385/rpmgf.v28i4.10955 · Cited by 5
Vila, T. F. I. (2015) · International Journal of Health Services · doi:10.1177/0020731415585976 · Cited by 5
“The relative risks of death and hospitalization for pneumonia during the influenza season found in this study were very similar to those in comparable cohort studies.(61) Only one prior study had analyzed the relative risks of the 2 hemi-cohorts before the influenza season.”
ResultFetterolf, D. E., & West, R. (2004) · American Journal of Medical Quality · doi:10.1177/106286060401900202 · Cited by 5
Torres, A. (2009) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0029-1202931 · Cited by 5
Influenza vaccination: the prevalence of risk factors in persons aged 60 years and more in Catalonia
Domı́nguez, Á., Juncà, S., Tresserres, R., Batalla, J., & Salleras, L. (2003) · Vacunas · doi:10.1016/s1576-9887(03)70339-2 · Cited by 5
Prevention of Pneumonia in the Hospital Setting
Osmon, S., & Kollef, M. H. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2004.10.008 · Cited by 5
Yuan, S., Wang, Y., Xie, Y., Dai, J., Leng, S. X., & You, L. (2025) · Vaccines · doi:10.3390/vaccines13121249 · Cited by 4
Hospital admissions related to influenza in France during the 2006/2007 epidemic
Tomas, J., Lelièvre, F., Bercelli, P., Glanddier, P. Y., Fanello, S., Tuffreau, F., & Tallec, A. (2011) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2011.01.005 · Cited by 5
Opportunities to improve influenza vaccination rates in general medical inpatients
Zaman, F. Y., Nagalingam, V., Wong, C., Khu, C. Y. L., Teng, H. W. G., Janardan, J., Ritchie, E., Cheng, A. C., & Aung, A. K. (2019) · Internal Medicine Journal · doi:10.1111/imj.14275 · Cited by 4
Wang, J., Yang, Y., Liu, C., Chang, K., Liu, C., & Liu, C. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04221-5 · Cited by 4
“Previous studies have revealed that NH residents with stroke are less inclined to receive a pneumococcal vaccine [41].”
BackgroundVaccination and neurological disorders
Γκαμπέτα, Α., Pavlidou, E., & Pavlou, E. (2015) · Journal of Pediatric Sciences · doi:10.17334/jps.87478 · Cited by 4
What Every Cardiologist Should Know about H1N1?
Golabchi, A., & Sarrafzadegan, N. (2010) · Europe PMC (PubMed Central) · Cited by 4
A Multiyear Model of Influenza Vaccination in the United States
Kamis, A. A., Zhang, Y., & Kamis, T. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14080849 · Cited by 4
Chen, C., Lin, C.-H., Chiu, C.-C., Yang, T. Y., Hsu, M., Wang, Y., Lei, M., Yeh, H., Fang, Y.-A., Hao, W., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.811021 · Cited by 4
“Previous nationwide studies conducted in Taiwan have indicated that influenza vaccination has benefits on cardiovascular and neurological outcomes (10, 14, 38).”
BackgroundChen, C.-I., Sung, L., Miser, J. S., Fang, Y.-A., Tsai, C.-Q., Liu, J., & Li, Y. (2013) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2013.02.002 · Cited by 4
New direction for medical research
Houck, P. D. (2010) · Heart Asia · doi:10.1136/ha.2010.001966 · Cited by 4
Disparities in risk status and influenza vaccination rates among the elderly
Nichol, K. L., Nordin, J. D., Mullooly, J. P., & Lask, R. (2004) · International Congress Series · doi:10.1016/j.ics.2004.02.035 · Cited by 4
Self-citationInfluenza vaccine in the elderly and chronic obstructive pulmonary disease
Lupatkin, H. (2005) · Current Infectious Disease Reports · doi:10.1007/s11908-005-0035-8 · Cited by 5
Бойцов, С. А., Лукьянов, М. М., Вячеславовна, П. Е., Gorbunov, V. M., Викторовна, Р. С., Назарова, О. А., Gille-Belova, O., Kravtsova, E. A., Довгалевский, П. Я., Фурман, Н. В., et al. (2014) · Russian Journal of Preventive Medicine · doi:10.17116/profmed201417613-20 · Cited by 4
Evidence of influenza or influenza-like-illness preceding acute coronary syndrome.
Kuanprasert, S., Apichartpikul, N., Chuenkitmongkol, S., Wiangosot, W., Topaiboon, P., & Sukonthasarn, A. (2008) · PubMed · Cited by 4
Pyogenic Bacterial Pneumonia and Lung Abscess
Torres, A., Menéndez, R., & Wunderink, R. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00032-8 · Cited by 4
Murine Models of Infectious Diseases in the Aged
High, K. P. (2006) · Elsevier eBooks · doi:10.1016/b978-012369391-4/50054-0 · Cited by 4
An outbreak of Severe Acute Respiratory Syndrome in a nursing home: Lessons to learn
Ho, W. W., Hui, E., Kwok, T. C. Y., & Woo, J. (2004) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2004.00195.x · Cited by 4
Influenza vaccination to prevent myocardial infarction
KELLER, T. T., Mairuhu, A., Brandjes, D. P. M., & Levi, M. M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005050 · Cited by 4
Influenza vaccination: an emerging opportunity to prevent cardiovascular disease
Madjid, M., Litovsky, S. H., Vela, D. C., & Casscells, S. W. (2004) · International Congress Series · doi:10.1016/j.ics.2004.02.030 · Cited by 4
Volpe, M., Battistoni, A., Gabutti, G., Bonanni, P., Nati, G., & Siliquini, R. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134178 · Cited by 3
2024-2025 COVID-19 Vaccine and Major Adverse Cardiovascular Events Among US Veterans
Cai, M., Xie, Y., & Al‐Aly, Z. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2026.1929 · Cited by 5
Royo‐Bordonada, M. Á., Bejarano, J. M. L., Alvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano‐Álvarez, A., Lizarbe, V., et al. (2013) · Neurología · doi:10.1016/j.nrl.2013.04.011 · Cited by 3
Dynamics of Single-City Influenza with Seasonal Forcing: From Regularity to Chaos
Thornley, J. H. M., & France, J. (2012) · ISRN Biomathematics · doi:10.5402/2012/471653 · Cited by 3
“The contribution of influenza to these excess deaths is disputed [35, 36], as vaccination against influenza protects against deaths from other conditions [37].”
BackgroundSurvey of Australian Inpatients on Vaccination Status and Perceptions of Influenza Vaccination
Loke, X. Y., Tran, W., & Alderman, C. P. (2012) · The Consultant Pharmacist · doi:10.4140/tcp.n.2012.553 · Cited by 3
Cytomegalovirus chronic infection as a risk factor for stroke: a prospective study
Ķēniņa, V., Auce, P., Priede, Z., Irbe, I., Vainšteina, L., Smeltere, E., & Millers, A. (2010) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/v10046-010-0023-8 · Cited by 3
“Infectious agents are essential for the immune system activation; it has been shown that flu vaccinated individuals less frequently develop acute vascular events, compared to unvaccinated people (Nichol et al., 2003; Smeeth et al., 2004).”
BackgroundRoyo‐Bordonada, M. Á., Bejarano, J. M. L., Alvarez, F. V., Sans, S., Pérez, A., Pedro‐Botet, J., Carriles, R. M. M., Maiques, A., Lizcano‐Álvarez, A., Lizarbe, V., et al. (2013) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2013.03.003 · Cited by 5
Janbakhsh, A., Mansouri, F., Vaziri, S., Sayad, B., Afsharian, M., Rezaei, M., & Heidari, S. (2016) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Kirmānshāh · doi:10.22110/jkums.v20i1.3122 · Cited by 3
“Studies have shown that vaccination in the elderly causes decreased mortality and coronary events (heart attack) during influenza season (3).”
BackgroundAssessing influenza-related mortality: Comment on Zucs et al.
Dushoff, J. G. (2005) · Emerging Themes in Epidemiology · doi:10.1186/1742-7622-2-7 · Cited by 3
“Retrospective cohort studies have shown a surprisingly large protective effect of influenza vaccination against deaths from any cause [3-5], and one author has provocatively suggested that increased influenza vaccination of the elderly could halve the total mortality rate [6].”
Patterns of Influenza Vaccination among Stroke Survivors
Sanossian, N., Gatto, N. M., & Ovbiagele, B. I. (2008) · Neuroepidemiology · doi:10.1159/000186500 · Cited by 3
Influenza vaccination of the elderly is associated with direct medical care cost savings
Nichol, K. L., Nordin, J. D., Mullooly, J. P., & Lask, R. (2004) · International Congress Series · doi:10.1016/j.ics.2004.02.037 · Cited by 3
Self-citationLuft, V. C., Giugliani, C., Harzheim, E., Schmidt, M. I., & Duncan, B. B. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.06.026 · Cited by 3
“28) Influenza vaccination [14] 0.”
InfluentialSecondary prevention of stroke: an evidence-based clinical audit in the primary care.
Chen, C. X., Chan, S. L., Law, T., Choi, S.-M., & Chan, K.-C. (2011) · PubMed · Cited by 3
Schoffer, O., Gottschalk, A., Liang, L. A., Werblow, A., Schriefer, D., Peschel, P., Karmann, A. J., Kügler, J., & Klug, S. J. (2019) · Journal of Public Health · doi:10.1007/s10389-019-01155-4 · Cited by 3
Karen Dintrans, A., Andrade, C. L., Sánchez, J. E., & Juan Mendoza, N. (2005) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482005000100003 · Cited by 3
Viral pneumonia and respiratory sepsis: Association, causation, or it depends?*
Parienti, J., & Carrat, F. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000254037.56888.cc · Cited by 3
The evidence, ethics and politics of mandatory health care worker vaccination
Born, K. B., Ikura, S., & Laupacis, A. (2014) · Journal of Health Services Research & Policy · doi:10.1177/1355819614546960 · Cited by 3
“Vaccination programmes for residents of hospitals and seniors’ residences have been shown to reduce morbidity and mortality.(2) Influenza vaccination is also recommended for health care workers in hospitals and in seniors’ residences (care homes) because of the risks of transmitting influenza to their patients.”
BackgroundSpark That Lights the Fire: Infection Triggers Cardiovascular Events
Santos‐Gallego, C. G., García‐Ropero, Á., & Badimón, J. J. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.011175 · Cited by 3
Chen, J., Zhou, W., Cen, M., Chen, C., Cao, K., Chen, M., Qu, R., Miao, J., Qi, J., Wu, X., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13238-2 · Cited by 2
“Crucially, evidence demonstrates that influenza vaccination reduces cerebrovascular events [31, 32], thereby directly mitigating dementia risk in these vulnerable groups.”
Wang, Y., Xu, W., Jin, C., Wang, S., Yan, Q., Wu, F., Huang, Z., Yu, K., Cheng, M., & Shi, Y. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70044 · Cited by 3
Fonseca, H. A. R., Silva, G. S., Monfardini, F., Nicolau, J. C., Rizzo, L. V., & Berwanger, O. B. (2025) · International Journal of Stroke · doi:10.1177/17474930251383626 · Cited by 2
“22,23 Randomized clinical trials specifically targeting influenza vaccination in patients who are high-risk or have a history of stroke could provide valuable insights into the vaccine’s efficacy and its potential impact on reducing influenza-related complications for the stroke population.”
Effectiveness of an Active Offer of Influenza Vaccination to Hospitalized Frail Patients
Fallucca, A., Anzà, D., Costantino, C., Genovese, C., Genovese, G., Rizzo, C. E., Vitello, T., Zagra, L., & Restivo, V. (2025) · Vaccines · doi:10.3390/vaccines13111165 · Cited by 2
“In particular, vaccination has been shown to decrease the risk of hospitalization for heart and cardiovascular diseases by approximately 20% and to reduce the likelihood of stroke [10,11].”
Espersen, C., Johansen, N. D., Vaduganathan, M., Bhatt, A. S., Modin, D., Skaarup, K. G., Chatur, S., Claggett, B. L., Janstrup, K. H., Larsen, C. S., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf160 · Cited by 2
“13 Influenza vaccination has been associated with a lower risk of CV fatal and non-fatal events 14–20 including AF.”
Šín, R., Lochmannová, A., Green, G., & Kubiska, M. (2026) · European Geriatric Medicine · doi:10.1007/s41999-026-01477-z · Cited by 2
“Among adults aged 65 years and older, influenza accounts for most related hospitalisations and deaths [2, 3, 5, 6], while vaccination reduces the risk of serious complications and mortality [7, 8].”
Steele, L. E., Tilstra, A. M., Short, K. R., Mamelund, S., & Wrigley‐Field, E. (2026) · International Journal of Epidemiology · doi:10.1093/ije/dyag061 · Cited by 2
“…directly attributable to the causative agent of a pandemic; historically, indirect causes of death resulting from influenza pandemics—which may not be included in mortality totals for P&I causes—include coinfections [34, 35], heart disease [34, 36], cancer [34], stroke [36], and malnutrition [35].”
Immune Modulation as a Therapeutic Strategy for Atherosclerosis
Mundkur, L., & Kakkar, V. V. (2010) · Current Drug Therapy · doi:10.2174/157488510792927465 · Cited by 2
“In an indirect study Influenza vaccination was found to reduce the risk of heart diseases and reduce the mortality rate [135].”
BackgroundGasparini, R., Lucioni, C., Mazzi, S., Amicizia, D., & Panatto, D. (2013) · PharmacoEconomics Italian Research Articles · doi:10.1007/s40276-013-0016-0 · Cited by 2
Déclaration sur la vaccination antigrippale pour la saison 2013–2014
(CCNI), C. C. N. D. L. (2013) · Relevé des maladies transmissibles au Canada · doi:10.14745/ccdr.v39i00a04f · Cited by 2
Inactivated and Recombinant Influenza Vaccines
Patel, M. M., Grohskopf, L. A., Sambhara, S. R., Belser, J. A., Katz, J. M., & Fry, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00033-5 · Cited by 5
Risk of healthcare visits from influenza in subjects with diabetes and impacts of early vaccination
Horswell, R. L., Chu, S. T., Stone, A. E., Fort, D. G., Uwaifo, G. I., Fonseca, V. A., & Norton, E. B. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003841 · Cited by 2
Randomized Controlled Trial of Atorvastatin in Acute Influenza in the Emergency Department
Chase, M., Cocchi, M. N., Grossestreuer, A. V., Liu, X., Vine, J., Moskowitz, A. L., & Donnino, M. W. (2025) · Western Journal of Emergency Medicine · doi:10.5811/westjem.33580 · Cited by 2
Metadata
- Authors
- Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M.
- Affiliations
- University of Minnesota (US)
- HealthPartners (US)
- Kaiser Permanente (US)
- Centers for Disease Control and Prevention (US)
- ORCID
- Nordin, James
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1322-1332
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116971894
- Cited by
- 752
- References
- 42
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 23 · 2019: 26 · 2018: 29 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 29 · 2013: 42 · 2012: 50
- FWCI
- 45.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza vaccination, influenza, stroke, heart disease, hospitalization, older adults, pneumonia, mortality, ischemic heart disease, cerebrovascular disease, upper respiratory tract infection, managed care, community-dwelling older adults, vaccine effectiveness, dementia, comorbidities, subgroup analysis
- MeSH terms
- Aged, Aged, 80 and over, Female, Heart Diseases, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Male, Mortality, Pneumonia, Risk, Logistic Models, Odds Ratio, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.